Tuberculous female pelvic inflammatory disease
ICD-10 A18.17 is a billable code used to indicate a diagnosis of tuberculous female pelvic inflammatory disease.
Tuberculous female pelvic inflammatory disease (PID) is a rare but serious condition caused by the Mycobacterium tuberculosis bacteria affecting the female reproductive organs. This condition typically arises from the spread of tuberculosis from other sites in the body, such as the lungs, to the pelvic region. Symptoms may include pelvic pain, abnormal vaginal discharge, fever, and dysmenorrhea. Diagnosis often involves a combination of clinical evaluation, imaging studies such as ultrasound or MRI, and laboratory tests including sputum cultures and tuberculin skin tests. Treatment usually requires a prolonged course of antitubercular medications, which may include isoniazid, rifampicin, ethambutol, and pyrazinamide. Monitoring for drug resistance is crucial, as multidrug-resistant tuberculosis (MDR-TB) can complicate treatment. Public health implications are significant, as PID can lead to infertility and chronic pain, and it necessitates contact tracing and isolation procedures to prevent further transmission of tuberculosis. Given the complexities of diagnosing and treating this condition, accurate coding is essential for appropriate patient management and resource allocation.
Detailed records of diagnostic tests, treatment regimens, and follow-up care.
Patients presenting with pelvic pain and a history of tuberculosis.
Need for thorough documentation of drug resistance and public health reporting.
Comprehensive documentation of pelvic examinations, imaging studies, and treatment outcomes.
Women with unexplained infertility or chronic pelvic pain.
Awareness of the implications of tuberculosis on reproductive health.
Used to obtain tissue samples for diagnosis in suspected cases of tuberculous PID.
Document indication for biopsy and results.
Gynecologists should ensure thorough documentation of findings.
Common symptoms include pelvic pain, abnormal vaginal discharge, fever, and dysmenorrhea. Patients may also experience systemic symptoms such as weight loss and night sweats.
